COMMUNIQUÉS West-GlobeNewswire

Innovation Pharmaceuticals Brilacidin Oral Mucositis Program Moving Forward Based Upon Positive Anchoring Phase 2 Results and Increased Brilacidin Franchise Value

18/12/2017 - 13:30

BEVERLY, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today is pleased to provide an update on the developmental plan for [...]

Intellia Therapeutics Names John Leonard, M.D., President and Chief Executive Officer

18/12/2017 - 13:30

Dr. Leonard has successfully led the development and regulatory approval of breakthrough biopharmaceuticals Company’s pipeline continues to advance toward clinical development CAMBRIDGE, Mass., Dec. 18, 2017 (GLOBE [...]

Major shareholder announcement

18/12/2017 - 13:08

Orphazyme A/S Company announcement No. 17/2017 Major shareholder announcement Copenhagen, December 18, 2017 – With reference to company announcement no. 5/2017 dated November 16, 2017 regarding the result of the Initial [...]

Sanofi and Alnylam submit Marketing Authorization Application to the European Medicines Agency for patisiran for the treatment of hereditary ATTR amyloidosis

18/12/2017 - 13:01

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi and Alnylam submit Marketing Authorization Application to the European Medicines Agency for patisiran for the treatment of hereditary ATTR amyloidosis [...]

Sanofi et Alnylam présentent une demande d'autorisation de mise sur le marché à l'Agence européenne des médicaments pour le patisiran dans le traitement de l'amylose héréditaire à transthyrétine

18/12/2017 - 13:01

Communiqué de presse Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi et Alnylam présentent une demande d'autorisation de mise sur le marché à l'Agence européenne des médicaments pour le patisiran dans le traitement de [...]

Deciphera Pharmaceuticals, Inc. Added to Russell 2000® Index

18/12/2017 - 13:00

WALTHAM, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH ), a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, today [...]

Marrone Bio Innovations, Inc. Announces Comprehensive Financing and Debt Restructuring Transaction

18/12/2017 - 13:00

$30 Million Private Placement of Common Stock and Warrants Concurrent Conversion of $45 Million of Outstanding Debt into Equity Management to Host Corporate Update Conference Call to Discuss the Transaction on Monday, [...]

AxoGen Corporation Announces Avance® Nerve Graft Recipient Selected to Ride on Donate Life Rose Parade® Float

18/12/2017 - 13:00

ALACHUA, Fla., Dec. 18, 2017 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Dylan Harvey [...]

Urgent need for blood donors

18/12/2017 - 13:00

OTTAWA, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Canadian Blood Services is calling on eligible blood donors to help fill 35,000 appointments by Jan. 6 to ensure that Canadian patients continue to have access to the blood and [...]

BioDelivery Sciences Announces Notice of Allowance of Patent Strengthening Patent Protection on BELBUCA® to 2032

18/12/2017 - 13:00

RALEIGH, N.C., Dec. 18, 2017 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI ) announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance of BDSI’s patent application [...]

Abattis Announces Expansion of Northern Vine Dealer’s License

18/12/2017 - 13:00

VANCOUVER, British Columbia, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (" Abattis ") (CSE:ATT) (OTC:ATTBF) is pleased to announce that Health Canada has approved an amendment to the dealer’s license [...]

Apeiron Announces Publication of Clinical Data with Anti-GD2 Antibody Demonstrating Efficacy in Relapsed & Refractory High-Risk Neuroblastoma

18/12/2017 - 09:00

VIENNA, Austria, Dec. 18, 2017 (GLOBE NEWSWIRE) -- APEIRON Biologics AG, a company focused on cancer immunotherapy, today announced the publication of a successful clinical study in high-risk neuroblastoma patients in [...]

RECORDATI: ACQUIRES TRANSIPEG®, TRANSIPEGLIB® AND COLOPEG® FOR THE FRENCH MARKET

18/12/2017 - 08:32

Milan, 18 December 2017 - Recordati announces the purchase of three Bayer Consumer Health brands for the French market: Transipeg®, TransipegLib® and Colopeg®. Transipeg® and TransipegLib® are macrogol based laxatives [...]

Quit smoking, nicotine free: R-kioski to distribute Acetium® lozenge in Finland

18/12/2017 - 08:30

Biohit Oyj, Press release, December 18, 2017 at 9:30 am local time (EET) Biohit Oyj and R-kioski Oy have signed an agreement for the distribution of the smoking cessation product, Acetium lozenge in Finland. The [...]

Sensorion and Cochlear Announce Collaboration to Study Combination Therapies for Cochlear Implant Patients

18/12/2017 - 08:00

Sensorion and Cochlear will evaluate SENS-401 in combination with Cochlear’s cochlear implants in preclinical setting in 2018, with potential mid-stage clinical testing to begin as soon as 2019 Cochlear will invest [...]

Transparency notification

18/12/2017 - 07:31

Mechelen, Belgium; 18 December 2017; 7.30 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Gilead Sciences, Inc. Pursuant to Belgian transparency [...]

Cannabis Wheaton Income Corp. Announces Sustainable Growth Strategic Capital Corp. as New Wheaton Streaming Partner

18/12/2017 - 07:30

VANCOUVER, British Columbia, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V:CBW) (" Wheaton Income " or the " Company ") is pleased to announce that it has entered into a [...]

Targovax announces that TG02 has passed the initial safety review in the first-in-man clinical trial in colorectal cancer

18/12/2017 - 07:01

Oslo, Norway, 18 December 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces that TG02 has passed the initial planned safety [...]

SENS Research Foundation Receives $1 Million Bitcoin Donation From Pineapple Fund

16/12/2017 - 01:15

MOUNTAIN VIEW, Calif., Dec. 15, 2017 (GLOBE NEWSWIRE) -- SENS Research Foundation (SRF) announced today the receipt of a $1 million bitcoin donation from the Pineapple Fund . The Pineapple Fund recently announced its [...]